Bae, Jae Seok
Ahn, Jong-Hwa
Jang, Jeong Yoon
Cho, Sang Young
Kang, Min Gyu
Kim, Kye-Hwan
Park, Hyun Woong
Koh, Jin-Sin
Park, Yongwhi
Hwang, Seok-Jae
Kwak, Choong Hwan
Hwang, Jin-Yong
Tantry, Udaya S.
Gurbel, Paul A.
Jeong, Young-Hoon https://orcid.org/0000-0003-0403-3726
Funding for this research was provided by:
National Research Foundation of Korea (NRF-2015R1A5A2008833)
Article History
First Online: 11 April 2020
Compliance with ethical standards
:
: Dr. Jeong has received honoraria for lectures from AstraZeneca, Sanofi-Aventis, Daiichi Sankyo/Lilly, Haemonetics, Otsuka, Han-mi Pharmaceuticals and Yuhan Pharmaceuticals; and research grants or support from AstraZeneca, Korean Society of Interventional Cardiology, Han-mi Pharmaceuticals, Yuhan Pharmaceuticals, Otsuka and Haemonetics. Dr Gurbel reports serving as a consultant fees/receiving honoraria from Daiichi Sankyo, Bayer, AstraZeneca, Merck, Boehringer, New Haven Pharmaceuticals, Janssen, and CSL and receiving grants from the National Institutes of Health, Daiichi Sankyo, CSL, AstraZeneca, Harvard Clinical Research Institute, Haemonetics, New Haven Pharmaceuticals, Duke Clinical Research Institute, Sinnowa, and Coramed. Dr Gurbel has patents in the field of platelet function testing. The other authors report no conflicts of interest.